Atlas Trials

Sex Hormone Binding Globulin, Testosterone and Glycemic Control in Patients With Type 2 Diabetes

Clinical trial NCT03519529 · COMPLETED

Trial details

NCT number
NCT03519529
Sponsor
Nanjing First Hospital, Nanjing Medical University
Status
COMPLETED
Study type
OBSERVATIONAL
Type2 Diabetes
Start date
2015-01-01
Primary completion
2018-04-15
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.